13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001858703
申报总市值
US$6.6亿
US$6.6亿
72 檔
22.0%
Blue Owl Capital Holdings LP 在 Q2 2025 季度的美股仓位总计估值为 US$6.6亿，分散于 72 个持仓标的之中，反映其市场参与广度与投资规模。
Blue Owl Capital Holdings LP 在 Q2 2025 进行了结构性的板块轮动与仓位换股。在开立 9 个全新仓位及加仓 6 档持股的同时，亦同步清仓 8 档并减仓 13 档标的。
在资产配置集中度方面，Blue Owl Capital Holdings LP 的前 5 大核心持股（包含 NCDL, OBDC, CGEM 等）合计占整体申报市值的 22.0%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NCDL | Nuveen Churchill Direct Lend | 股票-其他 | 21.11% | -3.32% | — | |
| 2 | OBDC | Blue Owl Capital CORP | 股票-金融 | 9.46% | -2.73% | — | |
| 3 | CGEM | Cullinan Therapeutics Inc | 股票-其他 | 5.80% | -3.07% | -2.05% | |
| 4 | EVCM | Evercommerce Inc | 股票-其他 | 5.56% | — | — | |
| 5 | TRML | Tourmaline Bio Inc | 股票-其他 | 5.15% | — | -3.86% | |
| 6 | LRMR | Larimar Therapeutics Inc | 股票-其他 | 4.60% | -4.40% | +3.14% | |
| 7 | ✓ | Engene Holdings Inc | 股票-其他 | 4.38% | -8.08% | EXIT | |
| 8 | CNDT | Conduent Inc | 股票-其他 | 3.80% | -0.62% | -21.77% | |
| 9 | SGMT | Sagimet Biosciences Inc-a | 股票-其他 | 3.27% | +1.00% | — | |
| 10 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 3.00% | -0.78% | +66.56% | |
| 11 | HLLY | Holley Inc | 股票-其他 | 2.65% | -1.81% | -22.67% | |
| 12 | CVEO | Civeo CORP | 股票-其他 | 2.37% | -1.28% | EXIT | |
| 13 | CMPX | Compass Therapeutics Inc | 股票-其他 | 2.17% | -2.99% | -12.29% | |
| 14 | IRON | Disc Medicine Inc | 股票-其他 | 2.09% | — | -12.83% | |
| 15 | ✓ | Ikena Oncology Inc | 股票-其他 | 1.77% | — | — | |
| 16 | EYPT | Eyepoint Inc | 股票-其他 | 1.71% | -1.52% | -29.46% | |
| 17 | TEM | Tempus Ai Inc-cl A | 股票-医疗保健 | 1.64% | — | — | |
| 18 | CNTX | Context Therapeutics Inc | 股票-其他 | 1.57% | -3.34% | +0.54% | |
| 19 | RPTX | Repare Therapeutics Inc | 股票-其他 | 1.54% | — | — | |
| 20 | MLYS | Mineralys Therapeutics Inc | 股票-其他 | 1.47% | — | +62.85% | |
| 21 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 1.40% | — | +4.95% | |
| 22 | TNGX | Tango Therapeutics Inc | 股票-其他 | 1.35% | — | -61.61% | |
| 23 | ELDN | Eledon Pharmaceuticals Inc | 股票-其他 | 1.16% | -0.84% | -26.92% | |
| 24 | PLRX | Pliant Therapeutics Inc | 股票-其他 | 1.11% | -1.01% | EXIT | |
| 25 | AQST | Aquestive Therapeutics Inc | 股票-其他 | 0.98% | -0.91% | — | |
| 26 | PVLA | Palvella Therapeutics Inc | 股票-其他 | 0.91% | -0.22% | -10.69% | |
| 27 | STWD | Starwood Property Trust Inc | 股票-房地产 | 0.85% | -0.25% | — | |
| 28 | DELL | Dell Technologies -c | 股票-科技 | 0.82% | +1.53% | — | |
| 29 | BMEA | Biomea Fusion Inc | 股票-其他 | 0.76% | — | — | |
| 30 | ✓ | Adc Therapeutics SA | 股票-其他 | 0.63% | -0.58% | — | |
| 31 | FLD | Fold Holdings Inc | 股票-其他 | 0.62% | -0.24% | — | |
| 32 | VRNA | Verona Pharma PLC - Adr | 股票-其他 | 0.56% | — | — | |
| 33 | CABA | Cabaletta Bio Inc | 股票-其他 | 0.55% | +0.33% | NEW | |
| 34 | KRRO | Korro Bio Inc | 股票-其他 | 0.50% | — | — | |
| 35 | APGE | Apogee Therapeutics Inc | 股票-其他 | 0.49% | — | — | |
| 36 | TTAN | Servicetitan Inc-a | 股票-科技 | 0.39% | — | — | |
| 37 | EPD | Enterprise Products Partners | 股票-能源 | 0.31% | -0.32% | EXIT | |
| 38 | MRKR | Marker Therapeutics Inc | 股票-其他 | 0.27% | -0.07% | — | |
| 39 | CMPS | Compass Pathways PLC | 股票-其他 | 0.21% | +0.96% | NEW | |
| 40 | ✓ | 股票-其他 | 0.18% | — | — | ||
| 41 | ✓ | Alpha Modus Hldgs Inc | 股票-其他 | 0.13% | -0.04% | EXIT | |
| 42 | ✓ | Rezolve Ai LTD | 股票-其他 | 0.12% | -0.02% | -21.00% | |
| 43 | SLND-WS | Legato Merger CORP Ii -cw23 | 股票-其他 | 0.09% | -0.01% | — | |
| 44 | CAH | Cardinal Health Inc | 股票-医疗保健 | 0.09% | -0.10% | EXIT | |
| 45 | NIOBW | Niocorp Developments LTD -28 | 股票-其他 | 0.09% | -0.08% | -28.71% | |
| 46 | AMODW | Insight Acquisition Co -cw23 | 股票-其他 | 0.07% | -0.01% | — | |
| 47 | SHFS | Shf Holdings Inc | 股票-其他 | 0.05% | -0.02% | — | |
| 48 | BKSY-WS | Blacksky Technology -cw24 | 股票-其他 | 0.03% | — | — | |
| 49 | OPTXW | Omnilit Acquisition Cl A -23 | 股票-其他 | 0.02% | -0.23% | EXIT | |
| 50 | DAVEW | Dave Inc -cw27 | 股票-其他 | 0.02% | +0.01% | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | SGMT | Sagimet Biosciences Inc-a | +1.9% | — | 不变 |
| 2 | TEM | Tempus Ai Inc-cl A | +1.6% | NEW | 新建仓 |
| 3 | LRMR | Larimar Therapeutics Inc | +1.3% | +3.14% | 加仓 |
| 4 | RARE | Ultragenyx Pharmaceutical In | +1.2% | +66.56% | 加仓 |
| 5 | STWD | Starwood Property Trust Inc | +0.9% | NEW | 新建仓 |
| 6 | DELL | Dell Technologies -c | +0.8% | NEW | 新建仓 |
| 7 | BMEA | Biomea Fusion Inc | +0.8% | NEW | 新建仓 |
| 8 | FLD | Fold Holdings Inc | +0.6% | NEW | 新建仓 |
| 9 | CABA | Cabaletta Bio Inc | +0.6% | NEW | 新建仓 |
| 10 | KRRO | Korro Bio Inc | +0.5% | NEW | 新建仓 |
| 11 | APGE | Apogee Therapeutics Inc | +0.5% | NEW | 新建仓 |
| 12 | RPTX | Repare Therapeutics Inc | +0.5% | — | 不变 |
| 13 | MLYS | Mineralys Therapeutics Inc | +0.4% | +62.85% | 加仓 |
| 14 | TNGX | Tango Therapeutics Inc | +0.4% | -61.61% | 减仓 |
| 15 | TTAN | Servicetitan Inc-a | +0.4% | NEW | 新建仓 |
| 16 | CMPX | Compass Therapeutics Inc | +0.4% | -12.29% | 减仓 |
| 17 | EYPT | Eyepoint Inc | +0.3% | -29.46% | 减仓 |
| 18 | ✓ | Adc Therapeutics SA | +0.3% | — | 不变 |
| 19 | EVCM | Evercommerce Inc | +0.2% | — | 不变 |
| 20 | VRNA | Verona Pharma PLC - Adr | +0.2% | — | 不变 |
| 21 | AQST | Aquestive Therapeutics Inc | +0.1% | — | 不变 |
| 22 | CNTX | Context Therapeutics Inc | +0.1% | +0.54% | 加仓 |
| 23 | ✓ | +0.1% | — | 不变 | |
| 24 | ✓ | Rezolve Ai LTD | +0.1% | -21.00% | 减仓 |
| 25 | ✓ | Ikena Oncology Inc | +0.1% | — | 不变 |
| 26 | TRML | Tourmaline Bio Inc | +0.1% | -3.86% | 减仓 |
| 27 | MRKR | Marker Therapeutics Inc | +0.1% | — | 不变 |
| 28 | SLND-WS | Legato Merger CORP Ii -cw23 | +0.1% | — | 不变 |
| 29 | SHFS | Shf Holdings Inc | -0.1% | — | 不变 |
| 30 | 260 | Centessa Pharmaceuticals-adr | -0.1% | +4.95% | 加仓 |
| 31 | ROIV | Roivant Sciences Ltd. | -0.1% | EXIT | 清仓 |
| 32 | CGEM | Cullinan Therapeutics Inc | -0.2% | -2.05% | 减仓 |
| 33 | IRON | Disc Medicine Inc | -0.2% | -12.83% | 减仓 |
| 34 | PLRX | Pliant Therapeutics Inc | -0.2% | — | 不变 |
| 35 | CVEO | Civeo CORP | -0.2% | -8.85% | 减仓 |
| 36 | OBDC | Blue Owl Capital CORP | -0.2% | — | 不变 |
| 37 | GOCOQ | Gohealth Inc-class A | -0.2% | EXIT | 清仓 |
| 38 | ✓ | Inozyme Pharma Inc | -0.3% | EXIT | 清仓 |
| 39 | ✓ | Engene Holdings Inc | -0.4% | +13.68% | 加仓 |
| 40 | PVLA | Palvella Therapeutics Inc | -0.4% | -10.69% | 减仓 |
| 41 | ✓ | Marblegate Acquisition Corp | -0.4% | EXIT | 清仓 |
| 42 | NN | Nextnav Inc | -0.8% | EXIT | 清仓 |
| 43 | ELDN | Eledon Pharmaceuticals Inc | -0.8% | -26.92% | 减仓 |
| 44 | CMPS | Compass Pathways PLC | -0.8% | -79.76% | 减仓 |
| 45 | KROS | Keros Therapeutics Inc | -0.9% | EXIT | 清仓 |
| 46 | NCDL | Nuveen Churchill Direct Lend | -1% | — | 不变 |
| 47 | ETWOGBP | E2open Parent Holdings Inc | -1.1% | EXIT | 清仓 |
| 48 | CNDT | Conduent Inc | -1.2% | -21.77% | 减仓 |
| 49 | HLLY | Holley Inc | -1.8% | -22.67% | 减仓 |
| 50 | TQQQ | Proshares Ultrapro Qqq | -3.2% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，Blue Owl Capital Holdings LP 在 Q2 2025 季度的美股持仓总市值约为 US$6.6亿，共申报了 72 个公开持股仓位。
在 Q2 2025 季度，Blue Owl Capital Holdings LP 按市值排列的前三大核心持股分别为：NCDL (21.1%)、OBDC (9.5%)、CGEM (5.8%)。其中最大持股仓位 NCDL 占据整体投资组合约 21.1% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
TEM
市值: US$509.4万
本季最大获利了结 / 清仓标的
TQQQ
前期市值: US$1002.8万
在 Q2 2025 季度中，Blue Owl Capital Holdings LP 共进行了 36 项持仓异动，包含新建仓 9 个仓位、加仓 6 个仓位、减仓 13 个仓位以及清仓 8 个仓位。 其中最大新建仓标的为 TEM。 本季清仓仓位包含 TQQQ。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。